Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

Protagonist Therapeutics Debt to Equity Ratio 2015-2018 | PTGX

Current and historical debt to equity ratio values for Protagonist Therapeutics (PTGX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Protagonist Therapeutics debt/equity for the three months ending September 30, 2018 was 0.00.
Protagonist Therapeutics Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.00B $0.12B 0.00
2018-06-30 $0.00B $0.11B 0.00
2018-03-31 $0.00B $0.12B 0.00
2017-12-31 $0.00B $0.12B 0.00
2017-09-30 $0.00B $0.06B 0.00
2017-06-30 $0.00B $0.06B 0.00
2017-03-31 $0.00B $0.08B 0.00
2016-12-31 $0.00B $0.09B 0.00
2016-09-30 $0.00B $0.10B 0.00
2016-06-30 $0.00B $-0.05B 0.00
2016-03-31 $0.00B $0.00B 0.00
2015-12-31 $0.00B $0.00B 0.00
2015-09-30 $0.00B $0.00B 0.00
2015-06-30 $0.00B $0.00B 0.00
2014-12-31 $0.00B $-0.01B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.197B $0.020B
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The Company's initial lead product candidates consists of PTG-100 and PTG-200, which have the potential to transform the existing treatment paradigm for inflammatory bowel disease, a GI disease consisting primarily of ulcerative colitis and Crohn's disease; PTG-300, an injectable hepcidin mimetic. Protagonist Therapeutics, Inc. is based in Milpitas, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $121.301B 13.72
Gilead Sciences (GILD) United States $91.265B 10.99
Biogen (BIIB) United States $63.175B 12.79
Celgene (CELG) United States $48.689B 9.45
Illumina (ILMN) United States $45.310B 52.78
Vertex Pharmaceuticals (VRTX) United States $42.060B 73.47
Regeneron Pharmaceuticals (REGN) United States $36.446B 18.49
Alexion Pharmaceuticals (ALXN) United States $25.904B 17.73
BioMarin Pharmaceutical (BMRN) United States $16.339B 0.00
Incyte (INCY) United States $13.652B 377.35
Seattle Genetics (SGEN) United States $8.501B 0.00
Exact Sciences (EXAS) United States $8.413B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.015B 51.25
QIAGEN (QGEN) Netherlands $7.819B 25.01
Sarepta Therapeutics (SRPT) United States $7.484B 0.00
BeiGene (BGNE) Cayman Islands $6.679B 0.00
Alnylam Pharmaceuticals (ALNY) United States $6.574B 0.00
Bluebird Bio (BLUE) United States $6.371B 0.00
Bio-Techne Corp (TECH) United States $6.096B 41.18
Galapagos (GLPG) Belgium $5.286B 0.00
Alkermes (ALKS) Ireland $5.128B 3300.00
Exelixis (EXEL) United States $5.011B 14.20
Amarin (AMRN) Ireland $4.712B 0.00
Horizon Pharma Public (HZNP) Ireland $3.560B 14.65
Immunomedics (IMMU) United States $3.504B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.454B 0.00
Emergent Biosolutions (EBS) United States $3.378B 28.46
Ligand Pharmaceuticals (LGND) United States $3.141B 24.03
Guardant Health (GH) United States $3.113B 0.00
Array BioPharma (ARRY) United States $3.096B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.973B 0.00
Allogene Therapeutics (ALLO) United States $2.881B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.863B 0.00
Repligen (RGEN) United States $2.797B 87.37
Genomic Health (GHDX) United States $2.737B 92.39
Blueprint Medicines (BPMC) United States $2.466B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.447B 0.00
Akcea Therapeutics (AKCA) United States $2.408B 0.00
Ascendis Pharma (ASND) Denmark $2.357B 0.00
China Biologic Products (CBPO) China $2.315B 16.48
Acceleron Pharma (XLRN) United States $2.310B 0.00
Allakos (ALLK) United States $2.277B 0.00
Halozyme Therapeutics (HALO) United States $2.215B 49.42
Myriad Genetics (MYGN) United States $2.209B 21.89
ACADIA Pharmaceuticals (ACAD) United States $2.193B 0.00
MyoKardia (MYOK) United States $2.177B 0.00
REGENXBIO (RGNX) United States $2.115B 28.37
Amicus Therapeutics (FOLD) United States $1.938B 0.00
Global Blood Therapeutics (GBT) United States $1.876B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.804B 0.00
Reata Pharmaceuticals (RETA) United States $1.785B 0.00
AnaptysBio (ANAB) United States $1.735B 0.00
Aimmune Therapeutics (AIMT) United States $1.698B 0.00
Denali Therapeutics (DNLI) United States $1.661B 0.00
Innoviva (INVA) United States $1.638B 9.26
Arena Pharmaceuticals (ARNA) United States $1.607B 0.00
Cambrex (CBM) United States $1.604B 11.98
Atara Biotherapeutics (ATRA) United States $1.545B 0.00
Spark Therapeutics (ONCE) United States $1.540B 0.00
Medicines (MDCO) United States $1.536B 0.00
G1 THERAPEUTICS (GTHX) United States $1.503B 0.00
NeoGenomics (NEO) United States $1.488B 123.08
Rubius Therapeutics (RUBY) United States $1.460B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.435B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.352B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.320B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.306B 0.00
Editas Medicine (EDIT) United States $1.286B 0.00
Insmed (INSM) United States $1.284B 0.00
Myovant Sciences (MYOV) United Kingdom $1.274B 0.00
Mirati Therapeutics (MRTX) United States $1.211B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.172B 93.13
IMMURON LTD (IMRN) Australia $1.160B 0.00
WAVE Life Sciences (WVE) Singapore $1.129B 0.00
Lion Biotechnologies (IOVA) United States $1.084B 0.00
Solid Biosciences (SLDB) United States $1.057B 0.00
Cellectis (CLLS) France $1.015B 0.00
Momenta Pharmaceuticals (MNTA) United States $0.995B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.984B 0.00
Sangamo Therapeutics (SGMO) United States $0.971B 0.00
Retrophin (RTRX) United States $0.968B 0.00
Audentes Therapeutics (BOLD) United States $0.960B 0.00
DBV Technologies (DBVT) France $0.934B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.913B 0.00
Acorda Therapeutics (ACOR) United States $0.885B 11.20
Alder BioPharmaceuticals (ALDR) United States $0.883B 0.00
Intra-Cellular Therapies (ITCI) United States $0.868B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.857B 0.00
UniQure (QURE) Netherlands $0.850B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.845B 0.00
Puma Biotechnology (PBYI) United States $0.837B 0.00
Aptinyx (APTX) United States $0.833B 0.00
Fate Therapeutics (FATE) United States $0.821B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.820B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.804B 0.00
Clovis Oncology (CLVS) United States $0.795B 0.00
Viking Therapeutics (VKTX) United States $0.784B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.775B 0.00
Revance Therapeutics (RVNC) United States $0.771B 0.00
Apellis Pharmaceuticals (APLS) United States $0.769B 0.00
Heska (HSKA) United States $0.746B 61.09
Coherus BioSciences (CHRS) United States $0.746B 0.00
Intellia Therapeutics (NTLA) United States $0.739B 0.00
Dynavax Technologies (DVAX) United States $0.720B 0.00
Cara Therapeutics (CARA) United States $0.712B 0.00
AVROBIO (AVRO) United States $0.704B 0.00
Vericel (VCEL) United States $0.702B 0.00
InflaRx (IFRX) Germany $0.702B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.687B 0.00
Athenex (ATNX) United States $0.684B 0.00
TWIST BIOSCIENC (TWST) United States $0.654B 0.00
UROGEN PHARMA (URGN) Israel $0.654B 0.00
Novavax (NVAX) United States $0.639B 0.00
CytomX Therapeutics (CTMX) United States $0.620B 0.00
ANI Pharmaceuticals (ANIP) United States $0.616B 11.81
AMAG Pharmaceuticals (AMAG) United States $0.588B 0.00
AC Immune SA (ACIU) Switzerland $0.582B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.578B 0.00
Gritstone Oncology (GRTS) United States $0.576B 0.00
Epizyme (EPZM) United States $0.575B 0.00
Principia Biopharma (PRNB) United States $0.572B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.567B 0.00
Scholar Rock Holding (SRRK) United States $0.558B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.533B 0.00
Arvinas (ARVN) United States $0.529B 0.00
Senesco Technologies (ELOX) United States $0.526B 0.00
UNITY Biotechnology (UBX) $0.510B 0.00
Eidos Therapeutics (EIDX) United States $0.505B 0.00
Arcus Biosciences (RCUS) United States $0.504B 0.00
Anika Therapeutics (ANIK) United States $0.503B 20.81
Kezar Life Sciences (KZR) United States $0.492B 0.00
ObsEva SA (OBSV) Switzerland $0.486B 0.00
BeyondSpring (BYSI) United States $0.483B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.468B 0.00
Inovio Pharmaceuticals (INO) United States $0.468B 0.00
Mesoblast (MESO) Australia $0.464B 0.00
Replimune (REPL) United States $0.444B 0.00
Prothena (PRTA) Ireland $0.440B 0.00
Kura Oncology (KURA) United States $0.434B 0.00
PDL BioPharma (PDLI) United States $0.425B 6.93
RA PHARMCTL INC (RARX) United States $0.421B 0.00
Sinovac Biotech (SVA) China $0.420B 0.00
Kindred Biosciences (KIN) United States $0.417B 0.00
MediciNova (MNOV) United States $0.412B 0.00
Zymeworks (ZYME) Canada $0.409B 0.00
Sorrento Therapeutics (SRNE) United States $0.402B 65.80
Five Prime Therapeutics (FPRX) United States $0.389B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.384B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.380B 0.00
Stemline Therapeutics (STML) United States $0.364B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.363B 0.00
Osiris Therapeutics (OSIR) United States $0.361B 0.00
Abeona Therapeutics (ABEO) United States $0.360B 0.00
Zealand Pharma (ZEAL) Denmark $0.354B 0.00
Verastem (VSTM) United States $0.353B 0.00
Liquidia Technologies (LQDA) United States $0.343B 0.00
MeiraGTx Holdings (MGTX) United States $0.342B 0.00
Seres Therapeutics (MCRB) United States $0.338B 0.00
Cytokineticsorporated (CYTK) United States $0.338B 0.00
LogicBio Therapeutics (LOGC) United States $0.330B 0.00
ResTORbio (TORC) United States $0.329B 0.00
Kodiak Sciences (KOD) United States $0.316B 0.00
Krystal Biotech (KRYS) United States $0.313B 0.00
Merus (MRUS) Netherlands $0.306B 0.00
Cellular Biomedicine (CBMG) United States $0.304B 0.00
Albireo Pharma (ALBO) United States $0.299B 0.00
MannKind (MNKD) United States $0.284B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.284B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.283B 0.00
Geron (GERN) United States $0.281B 0.00
Kadmon Holdings (KDMN) United States $0.277B 0.00
Celyad SA (CYAD) Belgium $0.274B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.270B 0.00
Equillium (EQ) United States $0.266B 0.00
Sutro Biopharma (STRO) United States $0.265B 0.00
Aduro Biotech (ADRO) United States $0.264B 0.00
Celcuity (CELC) United States $0.261B 0.00
Athersys (ATHX) United States $0.259B 0.00
BioDelivery Sciences (BDSI) United States $0.253B 0.00
Syros Pharmaceuticals (SYRS) United States $0.252B 0.00
Agenus (AGEN) United States $0.247B 0.00
Arbutus Biopharma (ABUS) Canada $0.243B 0.00
Unum Therapeutics (UMRX) United States $0.240B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.239B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.237B 0.00
TOCAGEN INC (TOCA) United States $0.237B 0.00
Evelo Biosciences (EVLO) United States $0.233B 0.00
Axovant Sciences (AXON) United Kingdom $0.232B 0.00
ADMA Biologics Inc (ADMA) United States $0.232B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.231B 0.00
BioTime (BTX) United States $0.229B 0.00
Strongbridge Biopharma (SBBP) United States $0.227B 0.00
Proteostasis Therapeutics (PTI) United States $0.225B 0.00
Adverum Biotechnologies (ADVM) United States $0.224B 0.00
Magenta Therapeutics (MGTA) United States $0.221B 0.00
Urovant Sciences (UROV) United States $0.217B 0.00
Kamada (KMDA) Israel $0.216B 19.83
Synlogic (SYBX) United States $0.215B 0.00
Kala Pharmaceuticals (KALA) United States $0.214B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.210B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.199B 0.00
Idera Pharmaceuticals (IDRA) United States $0.195B 0.00
Intec Pharma (NTEC) Israel $0.191B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.188B 0.00
ChromaDex (CDXC) United States $0.187B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.179B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.177B 0.00
NantKwest (NK) United States $0.174B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.171B 0.00
Palatin Technologies (PTN) United States $0.169B 20.75
Compugen (CGEN) Israel $0.167B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.165B 0.00
Allena Pharmaceuticals (ALNA) United States $0.164B 0.00
Cerecor (CERC) United States $0.157B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.155B 0.00
PSivida (EYPT) United States $0.153B 0.00
Pfenex (PFNX) United States $0.149B 0.00
Menlo Therapeutics (MNLO) United States $0.149B 0.00
Constellation Pharmaceuticals (CNST) United States $0.149B 0.00
Enzo Biochem (ENZ) United States $0.148B 0.00
Mersana Therapeutics (MRSN) United States $0.146B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.145B 0.00
XBiotech (XBIT) United States $0.145B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.144B 0.00
Spero Therapeutics (SPRO) United States $0.143B 0.00
Cohbar (CWBR) United States $0.138B 0.00
Pluristem Therapeutics (PSTI) Israel $0.133B 0.00
Organovo Holdings (ONVO) United States $0.127B 0.00
Selecta Biosciences (SELB) United States $0.127B 0.00
Eleven Biotherapeutics (SESN) United States $0.124B 0.00
Applied Genetic Technologies (AGTC) United States $0.124B 0.00
Catalyst Biosciences (CBIO) United States $0.123B 0.00
VBI Vaccines (VBIV) United States $0.120B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.120B 0.00
Cue Biopharma (CUE) United States $0.115B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.114B 0.00
CorMedix Inc (CRMD) United States $0.114B 0.00
XOMA (XOMA) United States $0.112B 0.00
OVID THERAPEUTC (OVID) United States $0.112B 0.00
Anavex Life Sciences (AVXL) United States $0.110B 0.00
Motif Bio Plc (MTFB) United States $0.109B 0.00
Mustang Bio (MBIO) United States $0.109B 0.00
Signal Genetics (MGEN) United States $0.108B 0.00
Cidara Therapeutics (CDTX) United States $0.107B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.101B 0.00
Provention Bio (PRVB) United States $0.098B 0.00
Chiasma (CHMA) United States $0.098B 0.00
ScPharmaceuticals (SCPH) United States $0.095B 0.00
Orgenesis (ORGS) United States $0.090B 0.00
PHASEBIO PHARMA (PHAS) United States $0.088B 0.00
Neothetics (EVFM) United States $0.088B 0.00
Axsome Therapeutics (AXSM) United States $0.084B 0.00
BioXcel Therapeutics (BTAI) United States $0.083B 0.00
Cocrystal Pharma (COCP) United States $0.082B 91.00
Ophthotech (OPHT) United States $0.079B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.079B 0.00
VolitionRX (VNRX) Singapore $0.077B 0.00
Checkpoint Therapeutics (CKPT) United States $0.077B 0.00
Monster Digital (INNT) United States $0.076B 0.00
Prima BioMed (IMMP) Australia $0.076B 0.00
Cel-Sci (CVM) United States $0.075B 0.00
Aptose Biosciences (APTO) Canada $0.074B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Aptevo Therapeutics (APVO) United States $0.070B 0.00
Bionano Genomics (BNGO) United States $0.070B 0.00
Alimera Sciences (ALIM) United States $0.070B 0.00
Versartis (ARAV) United States $0.070B 6.12
Evogene (EVGN) Israel $0.069B 0.00
NewLink Genetics (NLNK) United States $0.069B 0.00
VTv Therapeutics (VTVT) United States $0.069B 0.00
ITUS (ANIX) United States $0.067B 0.00
Asterias Biotherapeutics (AST) United States $0.067B 0.00
Alcobra (ARCT) United States $0.066B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.064B 0.00
Protalix BioTherapeutics (PLX) Israel $0.063B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.061B 0.00
VistaGen Therapeutics (VTGN) United States $0.060B 0.00
Entera Bio (ENTX) Israel $0.059B 0.00
Fortress Biotech (FBIO) United States $0.058B 0.00
Celldex Therapeutics (CLDX) United States $0.057B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.056B 9.00
Bellerophon Therapeutics (BLPH) United States $0.055B 0.00
Sophiris Bio (SPHS) United States $0.055B 0.00
Leap Therapeutics (LPTX) United States $0.053B 0.00
Oncobiologics (ONS) United States $0.053B 0.00
Trevena (TRVN) United States $0.052B 0.00
OncoSec Medical (ONCS) United States $0.049B 0.00
Caladrius Biosciences (CLBS) United States $0.049B 0.00
Clearside Biomedical (CLSD) United States $0.048B 0.00
Curis (CRIS) United States $0.047B 0.00
Oncolytics Biotech (ONCY) Canada $0.047B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.045B 0.00
Zosano Pharma (ZSAN) United States $0.045B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.043B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.041B 0.00
AEterna Zentaris (AEZS) United States $0.040B 7.59
TRACON Pharmaceuticals (TCON) United States $0.039B 0.00
AquaBounty Technologies (AQB) United States $0.039B 0.00
Galena Biopharma (SLS) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.037B 0.00
Celsion (CLSN) United States $0.037B 0.00
AZURRX BIOPHARM (AZRX) United States $0.036B 0.00
Moleculin Biotech (MBRX) United States $0.034B 0.00
BioPharmX (BPMX) United States $0.034B 0.00
VIVUS (VVUS) United States $0.034B 0.00
GTx (GTXI) United States $0.034B 0.00
Aileron Therapeutics (ALRN) United States $0.033B 0.00
Eyenovia (EYEN) United States $0.031B 0.00
Proteon Therapeutics (PRTO) United States $0.030B 0.00
Therapix Biosciences (TRPX) Israel $0.028B 10.27
Vical (VICL) United States $0.027B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.026B 0.00
Advaxis (ADXS) United States $0.026B 0.00
Benitec Biopharma (BNTC) Australia $0.025B 0.00
OvaScience (OVAS) United States $0.024B 0.00
Cellect Biotechnology (APOP) Israel $0.024B 0.00
CytRx (CYTR) United States $0.022B 0.00
Edge Therapeutics (EDGE) United States $0.021B 0.00
Novelion Therapeutics (NVLN) Canada $0.020B 0.00
GENPREX INC (GNPX) United States $0.020B 0.00
Pulmatrix (PULM) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Gemphire Therapeutics (GEMP) United States $0.018B 0.00
Arsanis (ASNS) United States $0.017B 0.00
TrovaGene (TROV) United States $0.017B 0.00
Soligenix (SNGX) United States $0.017B 0.00
RestorGenex (DFFN) United States $0.016B 0.00
Prana Biotechnology (PRAN) Australia $0.016B 0.00
ATyr Pharma (LIFE) United States $0.016B 0.00
IBio (IBIO) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Histogenics (HSGX) United States $0.012B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
Oragenics (OGEN) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.009B 0.00
Aytu Bioscience (AYTU) United States $0.009B 0.00
Alliqua BioMedical (ALQA) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Synthetic Biologics (SYN) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00